Suneva Medical and Neauvia North America Enter into a New Strategic Partnership

The partnership will help market and distribute Neauvia North America's Plasma IQ. Photo credit: Neauvia North America

Suneva Medical, a privately held aesthetics company, announced an exclusive strategic partnership to market and distribute Neauvia North America's Plasma IQ, the first Class 2 FDA cleared plasma energy device throughout North America. Plasma IQ is the latest advancement in aesthetics that delivers focused, controlled plasma energy to safely and effectively create microinjuries on the skin, renewing and restoring it. "We are looking forward to welcoming Plasma IQ to our ever-expanding portfolio of facial regenerative aesthetics products," says Pat Altavilla, CEO of Suneva Medical. "With the introduction of Plasma IQ, we continue our commitment to providing proven and validated innovations for aesthetic providers and their patients."


Tarsus Medical Group Debuts Dermatological Medical Education Hub

Sofwave Medical to Initiate Large-Scale Push Into North American Market

Venus Concept Announces FDA 510(k) Clearance for Venus Viva MD